Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we will assume that you are happy to receive all cookies and you will not see this message again. Click 'Find out more' for information on how to change your cookie settings.

The scheme is a collaboration between Oxford University, the global drug discovery company Evotec, and the investment fund Oxford Sciences Innovation (OSI).

Deborah Goberdhan portraitIn partnership with Evotec, a drug discovery company, Associate Professor Deborah Goberdhan has received a LAB282 award of half a million pounds to screen for inhibitors of proteins that selectively promote cancer growth. 

This award builds on over fifteen years of work, initiated and undertaken in Oxford, on the amino acid regulation of the growth-regulating kinase complex mTORC1 by so-called ‘transceptors’, proteins that look like transporters, but actually sense amino acids.

Prof Goberdhan commented: "We have taken this work forward translationally with an outstanding group of clinical collaborators in Oxford, facilitated by the Cancer Research UK Oxford Centre. We have also identified other putative regulators of cancer growth and progression, which we plan to develop in a similar way."

Similar stories

Cortex may regulate the need for sleep

Why we sleep, and the processes behind sleep, are amongst the most interesting questions in modern neuroscience. Researchers at the University of Oxford, including DPAG's Molnár and Vyazovskiy group scientists, have now uncovered a new target for sleep investigations within the mammalian brain – the cerebral cortex. The paper, first authored by Dr Lukas Krone, was published today in Nature Neuroscience.

Reducing fat in the diabetic heart could improve recovery from heart attack

New research from the Heather Group has shown that in type 2 diabetes an overload of lipids reduces the heart’s ability to generate energy during a heart attack, decreasing chances of recovery.

The brain’s one-sided teaching signals

A new study by the Lak group reveals a novel facet of dopamine signalling during visual decision making.

The prime of Professor Dame Kay Davies

Professor Dame Kay Davies, Professor of Genetics, first woman appointed Dr Lee's Professor of Anatomy at Oxford, first woman to become Head of Department for DPAG, University-wide champion of equality, and award winning scientist known for her work on Duchenne muscular dystrophy, has 'retired' after a lifetime's research, but remains Professor Emeritus at DPAG.

Fellowship awarded to Huriye Atilgan to enhance our understanding of value-based decision-making

Congratulations are in order for Postdoctoral Research Scientist Dr Huriye Atilgan who has been awarded a prestigious Sir Henry Wellcome Postdoctoral Fellowship funded by the Wellcome Trust.